No matter how cynical the overall market is Jaguar Health Inc (JAGX) performance over the last week is recorded 30.39%

Sana Meer

Jaguar Health Inc (NASDAQ: JAGX) established initial surge of 13.68% at $1.33, as the Stock market unbolted on Wednesday, before settling in for the price of $1.17 at the close. Taking a more long-term approach, JAGX posted a 52-week range of $1.00-$33.25.

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 86.61%. Meanwhile, its Annual Earning per share during the time was 86.61%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 92.27%. This publicly-traded company’s shares outstanding now amounts to $3.69 million, simultaneously with a float of $2.63 million. The organization now has a market capitalization sitting at $4.97 million. At the time of writing, stock’s 50-day Moving Average stood at $1.7480, while the 200-day Moving Average is $4.1303.

Jaguar Health Inc (JAGX) Ownership Facts and Figures

Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Jaguar Health Inc industry. Jaguar Health Inc’s current insider ownership accounts for 29.55%, in contrast to 2.55% institutional ownership.

Jaguar Health Inc (JAGX) Earnings and Revenue Records

Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.04 per share during the current fiscal year. Jaguar Health Inc’s EPS increase for this current 12-month fiscal period is 92.27% and is forecasted to reach -0.57 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 85.48% through the next 5 years, which can be compared against the 86.61% growth it accomplished over the previous five years trading on the market.

Jaguar Health Inc (NASDAQ: JAGX) Trading Performance Indicators

Let’s observe the current performance indicators for Jaguar Health Inc (JAGX). It’s Quick Ratio in the last reported quarter now stands at 0.52. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.42.

In the same vein, JAGX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -52.01, and analysts are predicting that it will be -0.57 at the market close of one year from today.

Technical Analysis of Jaguar Health Inc (JAGX)

Now, what If we examine the latest scores posted by [Jaguar Health Inc, JAGX]. During the last 5-days, its volume was better the volume of 0.13 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 50.00% While, its Average True Range was 52.76.

Raw Stochastic average of Jaguar Health Inc (JAGX) in the period of the previous 100 days is set at 20.00%, which indicates a major fall in contrast to 75.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1363 that was lower than 0.1553 volatility it exhibited in the past 100-days period.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.